Churg-Strauss Syndrome as an Unusual Aetiology of Stroke with Haemorrhagic Transformation in a Patient with No Cardiovascular Risk Factors
Open Access
- 21 January 2011
- journal article
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 3 (1) , 32-38
Abstract
Background: We present here a case of haemorrhagic brain infarction in a middle-aged and physically active male, who had never smoked. This case report aims to remind the internist and neurologist to bear in mind unusual aetiologies of brain infarcts in patients without classical cardiovascular risk factors. Case Description: A 49-year-old male with pulmonary asthma and a prior history of nasal polyps had a wake-up stroke with left-sided symptoms and speech disturbance. A head MRI and MR angiography revealed a recent haemorrhagic infarct in the right putamen and corona radiata. The left hemiparesis progressed to sensory-motor hemiplegia on the 4th day. In the head CT, it was shown that the haemorrhagic infarct had progressed to a large haematoma. A pansinusitis was also diagnosed. The aetiological investigations revealed a minor atrial septal defect (ASD) with shunting and a heterozygotic clotting factor V R506Q mutation. A remarkable blood eosinophilia of 9.80 E9/l (42%) together with fever, sinusitis, wide-spread bilateral nodular pulmonary infiltrates that did not respond to wide-spectrum antimicrobial treatment, positive anti-neutrophilic cytoplasmic antibodies, a high myeloperoxidase antibody level and slightly positive anti-proteinase 3 antibodies suggested the diagnosis of Churg-Strauss syndrome. These inflammatory symptoms and findings promptly responded to treatment with corticosteroids and cyclophosphamide. Conclusions: Even after the concomitant findings of the low risk factors, i.e. small ASD and heterozygotic clotting factor mutation, continued search for the final aetiology of stroke revealed Churg-Strauss syndrome, which was the key to the treatment.Keywords
This publication has 15 references indexed in Scilit:
- Prevention Strategies for Cardioembolic Stroke: Present and Future Perspectives~!2009-05-11~!2009-12-23~!2010-06-09~!The Open Neurology Journal, 2010
- Neurologic complications of Churg–Strauss syndrome – a prospective monocentric studyEuropean Journal of Neurology, 2010
- HLA-B35 Influences the Apoptosis Rate in Human Peripheral Blood Mononucleated Cells and HLA-Transfected CellsHuman Immunology, 2007
- HLA‐B35 upregulates the production of endothelin‐1 in HLA‐transfected cells: a possible pathogenetic role in pulmonary hypertensionTissue Antigens, 2006
- Antineutrophil cytoplasmic antibodiesThe Lancet, 2006
- Hypercoagulable States and Stroke: A Selective ReviewCNS Spectrums, 2005
- Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic SubtypesStroke, 2001
- Effect of a Single Amino Acid Change in MHC Class I Molecules on the Rate of Progression to AIDSNew England Journal of Medicine, 2001
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.Proceedings of the National Academy of Sciences, 1990